Executive summary
Founder mental health is not a soft topic, and in 2026 it is no longer an anecdotal one. Founders report burnout, anxiety and depression at rates well above the general adult population, and the majority never reach professional care. The most consequential fact is not the prevalence, it is the gap between how many founders are struggling and how few are treated. This paper puts numbers on that gap, explains why it persists, and describes the kind of confidential care founders will actually use.
Founders operate under sustained financial and reputational pressure while their identity and their company are hard to separate, so strain reads as commitment and is carried in private.
Generic wellness apps and investor-adjacent programs rarely reach founders, who fear that any disclosure of strain could shake the confidence of a board, an investor or a team, so the most acute distress is also the least treated.
Confidential, private-pay care delivered by licensed clinicians who understand startup pressure, on a route that does not run through investors or the cap table, in session formats long enough to do real work.
Care that a founder trusts turns hidden strain into an early, manageable problem, protecting both the person and the enterprise the strain would otherwise cost.
The problemThe most common startup risk no one underwrites§
Founder mental health strain is neither rare nor mild. In a survey of more than 400 startup founders, 72 percent said the entrepreneurial journey had affected their mental health.1 In peer reviewed research, 49 percent of entrepreneurs reported a lifetime mental health condition and mental health differences touched 72 percent of them directly or indirectly, with elevated rates of depression, ADHD and other conditions relative to a comparison group.2 More recent founder surveys are consistent: 54 percent reported burnout in the past twelve months and 75 percent reported anxiety,3 and a 2025 study of founders found 87 percent had experienced anxiety, depression or burnout, often all three.6 Against a general adult population in which roughly 23 percent experience any mental illness in a year, and in which anxiety disorders alone affect about 19 percent,5,11 these are not ordinary numbers. The elevated entrepreneur rates have been widely reported since Freeman's original study,12 national workforce surveys place work stress at the center of how employees describe their jobs,13 and burnout itself is now a recognized occupational phenomenon.10 For founders, strain is close to a baseline condition of the job.
The usual framing treats this as a personal wellness matter, which misses two things. First, the strain is structural. Founders carry financial risk, reputational exposure and a workload that 67 percent describe as more than 50 hours a week, and their identity is fused with the company in a way that makes ordinary recovery feel like disloyalty. Second, and more important, the distress is hidden. In the same large survey, 81 percent of founders said they do not openly share their stress, fears and challenges, and 90 percent do not discuss stress with their investors,1 a pattern echoed in contemporaneous reporting on the same research.9 A problem this widespread and this concealed does not show up in a board deck. It shows up later, as a resignation, a collapsed round, or a decision that quietly cost the company more than any program ever would.
The founder mental health crisis is not that so many are struggling. It is that so few of the ones struggling are ever treated. CEREVITY clinical whitepaper, 2026
The evidenceWhat the research shows§
The scale of founder distress can be read directly from published surveys rather than asserted, and the same sources reveal how little of it reaches care. The pattern is one CEREVITY clinicians recognize at the network level, and it is documented in detail in CEREVITY's account of how tech founders hide a mental health crisis. Four figures frame it: how common the strain is, how large the treatment gap is, the shape the concealment takes, and the downstream personal cost.
72%
of startup founders say the entrepreneurial journey has affected their mental health
Startup Snapshot, 2023
49%
of entrepreneurs report a lifetime mental health condition, against roughly 23% of adults overall
Freeman et al., 2019
23%
of founders have sought professional help, despite the strain being near universal
Startup Snapshot, 2023
87%
of founders report anxiety, depression or burnout, and often all three
Lehigh / Nasdaq, 2025
Read together, the figures establish a single pattern: near universal strain, minimal treatment. Anxiety, high stress and burnout run far above any general population baseline, yet in the large founder survey only 23 percent had sought professional help or seen a psychologist.1 The concealment is deliberate rather than accidental. Founders hide strain from cofounders, boards and investors because disclosure feels like a threat to the very confidence a startup runs on. The result is that the signal arrives late, usually as an exit or a mistake, which is exactly why CEREVITY's clinicians emphasize the early warning signs of founder burnout rather than waiting for a crisis to declare itself.
| Indicator | Figure | Population and sample | Source |
|---|---|---|---|
| Lifetime mental health condition | 49% | n = 242 entrepreneurs | Freeman et al., 20192 |
| Any mental illness, US adults (baseline) | 23.1% | 59.3M adults, 2022 | NIMH5 |
| Depression among entrepreneurs | 30% | n = 242 entrepreneurs | Freeman et al., 20192 |
| Burnout, past 12 months | 54% | n = 138 founders, 2025 | Sifted3 |
| Anxiety, past year | 75% | n = 138 founders, 2025 | Sifted3 |
| Considering leaving the startup this year | 49% | n = 156 founders, 2024 | Sifted4 |
| Have sought professional help | 23% | n > 400 founders, 2023 | Startup Snapshot1 |
03, 05 Sifted (2025), survey of 138 founders.
Baseline: National Institute of Mental Health, any mental illness among US adults, 2022.
01, 04 Startup Snapshot (2023), survey of more than 400 founders (strain 72%, sought help 23%).
Sifted (2024), survey of 156 founders (bad or very bad mental health 45%, regularly see a therapist 18%).
The frameworkA model you can name and own§
A problem that stays hidden has to be named before it can be caught. The Founder Concealment Model describes how founder distress moves through four phases, from a strain that reads as ordinary commitment to a rupture that finally becomes visible. Its value is practical: outward disclosure and help-seeking lag internal strain at every phase, so the earlier a phase is recognized, the more of the person and the company can be preserved.
CEREVITY model
The Founder Concealment Model
A four phase description of how founder distress stays hidden while it grows: the more a founder's identity is fused with the company, the more strain reads as dedication rather than a warning. Each phase names a pattern a clinician, a cofounder, or the founder themselves can recognize.
Fusion
Identity and enterprise merge. Long hours and lost recovery read as normal dedication, so early strain is reframed as proof of commitment rather than a signal to watch.
Overriding
The founder pushes through mounting symptoms to defend performance. Sleep and attention slip while results still hold, so the cost is real but not yet visible to anyone outside.
Concealment
Strain is actively hidden from cofounders, the board and investors. Help-seeking now feels like a risk to funding and confidence, so the founder gets more isolated exactly as the need for support peaks.
Rupture
A threshold breaks. Burnout, depression or a departure surfaces, and this is often the first moment anyone else sees the problem, when it is hardest and most expensive to treat.
The model points to one conclusion. Because disclosure lags strain, waiting for the problem to become visible guarantees meeting it at its worst. Recognizing the first two phases is the entire intervention, and specialized executive burnout therapy is built to act in that window rather than after the rupture.
SCHEMATIC Schematic, not measured data.
Conceptual model, CEREVITY. Curves are illustrative, not measured values.
By professionHow it presents across roles§
The same strain shows up differently depending on how a founder is funded and how they are structured, because the source of pressure and the audience they must hide it from change. Three groups illustrate the range, and each is a population CEREVITY clinicians see at the network level rather than a single diagnosis.
Venture-backed founders
For venture-backed founders, the pressure is amplified by the people funding them. Outside capital raises the stakes, the reporting cadence and the audience for any sign of weakness, and it adds a specific fear: that disclosing strain could shake investor confidence or complicate the next round. The data reflects it. In the largest founder survey, 90 percent of founders said they do not discuss stress with their investors,1 and in a 2025 survey 56 percent reported receiving no mental health support from their investors at all.3 Investor-side research reaches the same place from the other direction: only about a third of founders say they often turn to their investors for professional support, and 88 percent of founders agree that excessive stress can result in bad decision making, with 64 percent saying it can negatively affect business performance.14 What CEREVITY clinicians observe at the network level is a founder who is performing confidence full time for a board while carrying strain with nowhere to route it. The financial logic for a fund is direct: a founder operating in the concealment phase makes worse capital-allocation and hiring calls, and those choices compound across the whole company. Increasingly, mental health support is offered at the fund level precisely so that the route to care does not run through the cap table.
Individual therapy for founders
Organizational founder mental health partnership for VC firms
Solo founders and small-business owners
Solo founders and bootstrapped owners carry a different version of the problem, defined by isolation rather than investor pressure. Roughly 29 percent of surveyed founders operate solo,3 and without a cofounder to share the load there is no one inside the business who sees the strain early. Loneliness is one of the most common complaints in this group: in one survey of entrepreneurs, 26.9 percent named loneliness or isolation as a primary struggle,7 and among leaders more broadly, half of surveyed CEOs report loneliness in the role, with 61 percent of those saying it hinders their performance.15 The economic cushion is thinner too. Bootstrapped owners face personal financial exposure directly, and financial stress is a recognized distraction from running the business.14 At the network level, the pattern CEREVITY clinicians see is a founder who is the entire company, so stepping back for care feels impossible and the strain has no outlet. Awareness of tailored support is low: only 18.5 percent of entrepreneurs in one survey knew of mental health resources designed for people in their position.7 For this group, the care that works has to be low-friction, genuinely confidential, and priced and scheduled around a person who cannot simply delegate their way to a free afternoon.
Individual therapy for business owners
Organizational group-rate therapy benefit for solo and small firms
Tech founders and technical cofounders
Tech founders and technical cofounders sit at the sharp end of the concealment pattern, because the culture prizes relentless execution and treats vulnerability as a liability in a category built on projecting momentum. The surveys that isolate this group find the highest concealment: reporting on tech founders specifically has documented a hidden mental health crisis, and CEREVITY's own review of the segment describes the same silence. In the broader founder data, 83 percent reported high stress and 54 percent reported insomnia in the past year,3 and among a 2025 cohort 87 percent had experienced anxiety, depression or burnout.6 The through line for technical founders is that the same traits that make them effective, deep focus and an appetite for problem solving, make it easy to route every waking hour into the product and call it discipline. What CEREVITY clinicians observe at the network level is a founder fluent in systems and reluctant to treat their own mind as one of them. Because these founders are often the technical and cultural core of a venture-backed company, their strain propagates quickly to the teams that depend on their steadiness, which is why confidential care built around unpredictable schedules matters as much here as anywhere.
Individual therapy for CTOs and tech leaders
Organizational leadership mental health for venture-backed startups
The stakesThe cost of inaction§
The cost of untreated founder strain is not abstract, and it is not only the founder's. It lands in three places at once: the founder's health, the business, and the relationships that sustain both.
The personal health cost
The first cost is borne by the founder directly. Among founders surveyed in 2025, 75 percent reported anxiety, 83 percent reported high stress and 54 percent reported insomnia in the past year, and 46 percent rated their current mental health as bad or very bad.3 These are the raw materials of depression and burnout, and left untreated they compound.
The business cost
The second cost lands on the company. Nearly half of founders, 49 percent, said they were considering leaving their startup within the year,4 and founders themselves connect strain to performance: 88 percent agree excessive stress leads to bad decision making and 64 percent say it can negatively affect business performance.14 Because a founder sits upstream of every major decision, degraded judgment does not stay contained. It shows up in hiring, capital allocation and the direction of the whole venture.
The relational and social cost
The third cost is relational, and it is where recovery capacity quietly erodes. In founder surveys, 64 percent reported spending less time with family and friends, 62 percent took fewer holidays and 57 percent were exercising less.4 Loneliness is a defining feature of the role rather than a side effect,7 and each of these losses removes one of the buffers that would otherwise absorb strain before it becomes clinical.
04 Sifted (2024), survey of 156 founders.
The solutionWhat effective care looks like§
Good care for founders starts from a precise diagnosis of why the existing options fail. The barrier is rarely access to therapy in the abstract, it is access to therapy a founder will trust and use. That requires four things: genuine confidentiality with no route back to investors or a board, clinicians who understand startup pressure rather than being startled by it, low enough friction that a person who cannot delegate can still show up, and sessions long enough to do more than check a box. Awareness is part of the problem too, since only a small minority of founders even know that care built for them exists.
In practice this describes how CEREVITY is built. It is a nationwide network of independent licensed clinicians, matched to the person and delivered by secure video on a private-pay basis that keeps the work confidential. Ongoing work happens in 50-minute therapy sessions, with 90-minute therapy sessions when a single hour is not enough to get anywhere.
For founders facing an acute stretch, a launch, a raise, a crisis, CEREVITY also offers 3-hour therapy intensives that concentrate meaningful work into a single day. The private-pay model is deliberate: no insurance diagnosis code and no shared record, so nothing routes back to the cap table, and it is explained in full in how CEREVITY approaches this work.
ImplementationHow to put it into practice§
Turning this into action does not require a wellness overhaul. For a founder, an operator or an investor, it is four concrete steps, ordered from lowest effort to highest return.
- 01
Name the strain honestly
Replace the language of toughness with an accurate read of the phase. Rising hours, shrinking recovery and slipping sleep are the first two phases of concealment, not proof of commitment. A strain that is named early is one that can still be caught cheaply.
- 02
Separate care from the cap table
Founders avoid any route to help they believe could reach investors or a board. Provide or choose a confidential, independent, private-pay option with no shared record, so the person most at risk will actually use it.
- 03
Match the clinician to the context
Founders need clinicians fluent in startup pressure, not surprised by an 80-hour week or a down round. Match on relevant experience, and use session formats long enough to do real work rather than a rushed check-in.
- 04
Make it a standing resource, not a rescue
Offer care before the rupture, at the fund or company level where possible, and normalize its use. The point is to move help-seeking out of the crisis phase, where it is least effective, and into the early phases, where it works.
RecommendationsWhere to start§
Clinical
Treat founder distress as a trajectory, not a mood
Founder strain has phases and predictable early signals. Confidential high-functioning anxiety and depression therapy works best when it reaches the founder in the fusion or overriding phase, before concealment hardens and a rupture forces the issue.
Clinical
Reach founders where standard care fails
The people most affected are the least likely to ask. Understanding how the strain actually presents, described in CEREVITY's account of what founder depression looks like and what helps, is what lets an investor, a cofounder or a partner intervene before a crisis.
Structural
Make confidentiality the precondition, not a feature
With 90 percent of founders unwilling to discuss stress with investors,1 confidentiality is not a nicety, it is the thing that converts an offered benefit into a used one. Private pay, no diagnosis code and no shared record are what make disclosure feel safe.
Structural
Fund care as portfolio protection, not perk
Judged as a wellness perk, founder mental health looks optional. Judged against a founder operating in the concealment phase, whose degraded decisions compound across a whole company, supporting one founder's care is among the cheapest risk reductions a fund can make. That is why it increasingly sits at the fund level rather than being left to each company.
FAQCommon questions§
Why is founder mental health so under-treated when the rates are this high?
Does therapy actually change business outcomes, or is it only about wellbeing?
What does confidential care a founder will actually use look like?
How does private-pay billing work?
How is my privacy protected?
MethodologyHow this paper was built§
Methodology
This paper synthesizes published research on founder and entrepreneur mental health, drawn from peer reviewed journals, large-scale founder surveys, investor-led wellbeing research, and government health statistics. Sources were identified through searches of PubMed, Google Scholar, and the publication libraries of the National Institute of Mental Health, the World Health Organization, the American Psychological Association, and specialist startup and venture publications including Sifted, Startup Snapshot, Balderton Capital and Fortune, covering material published between 2018 and 2026, with priority given to the most recent available figures. Every quantitative claim in this document is external and sourced. The core prevalence figures come from named surveys with stated samples: Startup Snapshot's 2023 Untold Toll report of more than 400 founders; the peer reviewed 2019 study by Freeman and colleagues of 242 entrepreneurs against a 93 person comparison group; Sifted's founder mental health surveys of 156 founders in 2024 and 138 founders in 2025; a 2025 study of 308 entrepreneurs conducted by researchers at Lehigh University, the Nasdaq Entrepreneurial Center and TU Dortmund; and a 227 person entrepreneur survey published by Founder Reports in 2025. General population baselines are drawn from the National Institute of Mental Health's most recent estimates, which put any mental illness among US adults at 23.1 percent for 2022. Several limitations should be explicit. First, survey definitions of burnout, stress and mental health differ across sources and rely on self-report, so figures are not strictly comparable between surveys and are presented for magnitude rather than head-to-head ranking. Second, founder surveys are often self-selected and skew toward respondents willing to discuss the topic, which can bias prevalence in either direction. Third, comparison of entrepreneur rates to general population rates involves different instruments and time frames and should be read as indicative rather than exact. Finally, this paper contains no CEREVITY internal client data. Where CEREVITY clinical observation is referenced, it describes network-level patterns that independent clinicians report seeing across the founder population, not a measured dataset, and it is labeled as such throughout. Framework-level analyses of workplace burnout as a recognized occupational phenomenon informed the structure of the recommendations.10
References
- 01Startup Snapshot. (2023). The Untold Toll: The Impact of Stress on the Well-being of Startup Founders and CEOs. startupsnapshot.com
- 02Freeman, M. A., Staudenmaier, P. J., Zisser, M. R., & Andresen, L. A. (2019). The prevalence and co-occurrence of psychiatric conditions among entrepreneurs and their families. Small Business Economics. link.springer.com
- 03Sifted. (2025). More than half of founders experienced burnout last year. sifted.eu
- 04Sifted. (2024). 49% of founders say they're considering quitting their startup this year. sifted.eu
- 05National Institute of Mental Health. (2023). Mental Illness. nimh.nih.gov
- 06Fortune. (2025). We studied America's entrepreneurs and found too many of them were burned out, anxious and depressed. fortune.com
- 07Founder Reports. (2025). Entrepreneur Mental Health Statistics. founderreports.com
- 08Jerusalem Post. (2023). 72% of start-up founders suffer from mental health issues, report. jpost.com
- 09Field, A. (2023). Startup Founders Report Entrepreneurship Is Taking A Toll On Their Mental Health. Forbes. forbes.com
- 10World Health Organization. (2019). Burn-out an occupational phenomenon: International Classification of Diseases. who.int
- 11National Institute of Mental Health. (2023). Any Anxiety Disorder. nimh.nih.gov
- 12Startup Grind. (2015). Genius in Madness? 72% of Entrepreneurs Affected by Mental Health Conditions. startupgrind.com
- 13American Psychological Association. (2024). 2024 Work in America Survey. apa.org
- 14Balderton Capital. (2024). The business case for founder wellbeing: reflections on our second annual survey. balderton.com
- 15Leading Edge Group, citing Harvard Business Review. (2019). More than 60% of CEOs believe loneliness hinders performance. leadingedgegroup.com
- 16Balderton Capital. (2024). Founder Wellbeing Report 2024. balderton.com
- 17StartupNation. (2024). Startup Pressure Is Real: Why 72% of Founders Struggle with Mental Health. startupnation.com
PhD, Licensed Psychologist
Dr. Carter is a Licensed Psychologist specializing in therapy for executives, entrepreneurs, and high-achieving professionals. Her work integrates cognitive behavioral therapy, acceptance and commitment therapy, and attachment-informed approaches calibrated to the demands of high-responsibility careers. She sees clients via CEREVITY's nationwide telehealth network.
Talk to someone who gets it.
If this paper describes something you recognize, a confidential conversation is the next step. CEREVITY matches you to an independent licensed clinician who works with people in your position.
Schedule consultationPrivate-pay, telehealth, nationwide. Questions: (562) 295-6650
